Buying From Mark Cuban’s Pharmacy Could Save Medicare Billions, Study Says

Medicare’s prescription-drug program could save billions of dollars annually if it purchased generic acid-reflux, cancer and other drugs from a new pharmacy backed by investor Mark Cubanaccording to Harvard Medical School researchers. Mr. Cuban, the billionaire internet entrepreneur and owner of the NBA’s Dallas Mavericks, launched his pharmacy in January with an eye toward disrupting … Read more

AbbVie Shares Drop Amid Missed Sales Expectations for Key Drugs

Text size AbbVie stock is up 15.4% so far this year. Courtesy of AbbVie In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key drugs missed Wall Street estimates. The company’s first-quarter earnings were roughly in line with Wall Street expectations. AbbVie (ticker: ABBV) … Read more

Sierra Oncology Stock Soars After $ 1.9 Billion Takeover by GSK

Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy US rare cancer therapy company Sierra Oncology for $ 1.9 billion in cash, as it looks to boost its portfolio of new specialty medicines. The UK drugmaker will pay … Read more

Stocks for the Recession That May — or May Not — Be Coming

Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week — and that’s a recession signal that is either like Paul Revere’s ride or the boy who cried wolf. The good news: Investors do not need to decide which just yet. … Read more

3M Stock Is Soaring. Thank you Johnson & Johnson.

3M stock is jumping Friday. The primary reason is not the broad market rally, although that helps. The best explanation for 3M’s rise comes from an odd source for an industrial conglomerate. Johnson & Johnson did it. 3M (ticker: 3M) stock is up about 4.6% in late trading Friday. Shares of J&J (ticker: JNJ) are … Read more

Opinion: AT&T and 4 more unloved dividend stocks to buy in a ‘risk-off’ era

With stocks off to one of their worst starts to the year since the 2008-2009 financial crisis, it’s no longer crazy to talk about a sustained period of market volatility or a prolonged “risk off” environment on Wall Street. The S&P 500 index SPX has fallen 5.3 %% year-to-date through Monday’s closing bell. And many … Read more